Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients
June 13, 2022 08:00 ET
|
Ekso Bionics Holdings, Inc.
First FDA Cleared Exoskeleton for Rehabilitation Use in Patients with Multiple Sclerosis RICHMOND, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the...
Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer
May 26, 2022 07:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Present at the H.C. Wainwright Global Investment Conference
May 17, 2022 16:05 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that...
Ekso Bionics Reports First Quarter 2022 Results
April 28, 2022 16:05 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Report First Quarter 2022 Financial Results on April 28
April 21, 2022 08:03 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Reports Fourth Quarter and Year End 2021 Results
February 24, 2022 16:05 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
February 17, 2022 08:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Announces Leadership Transition
January 21, 2022 16:01 ET
|
Ekso Bionics Holdings, Inc.
Board Member Steven Sherman to be Appointed CEO EVP Scott Davis to be Appointed President and COO CEO Jack Peurach to Leave the Company Effective January 21, 2022 RICHMOND, Calif., Jan. 21, 2022 ...
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results
January 10, 2022 09:00 ET
|
Ekso Bionics Holdings, Inc.
Company Achieves Record Quarterly Revenue of $3.9 million to $4.1 million1 RICHMOND, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an...
Ekso Bionics to Participate at the H.C. Wainwright BioConnect Virtual Conference
January 04, 2022 08:30 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that...